These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35562766)

  • 1. Correction to: Physicians' misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes.
    Morieri ML; Lamacchia O; Manzato E; Giaccari A; Avogaro A;
    Cardiovasc Diabetol; 2022 May; 21(1):73. PubMed ID: 35562766
    [No Abstract]   [Full Text] [Related]  

  • 2. Physicians' misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes.
    Morieri ML; Lamacchia O; Manzato E; Giaccari A; Avogaro A;
    Cardiovasc Diabetol; 2022 Apr; 21(1):57. PubMed ID: 35473579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics.
    Morieri ML; Avogaro A; Fadini GP;
    Cardiovasc Diabetol; 2020 Nov; 19(1):190. PubMed ID: 33172454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
    Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
    Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FACTORS INFLUENCING ACHIEVEMENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOALS IN MEXICO: THE INTERNATIONAL CHOLESTEROL MANAGEMENT PRACTICE STUDY.
    Bello-Chavolla OY; Aguilar-Salinas CA
    Rev Invest Clin; 2019; 71(6):408-416. PubMed ID: 31823964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
    Kones R
    Vasc Health Risk Manag; 2013; 9():617-70. PubMed ID: 24174878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic inertia in the management of hyperlipidaemia in type 2 diabetic patients: a cross-sectional study in the primary care setting.
    Man FY; Chen CX; Lau YY; Chan K
    Hong Kong Med J; 2016 Aug; 22(4):356-64. PubMed ID: 27313271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).
    Danchin N; Almahmeed W; Al-Rasadi K; Azuri J; Berrah A; Cuneo CA; Karpov Y; Kaul U; Kayıkçıoğlu M; Mitchenko O; Ruiz AJ; Aguilar Salinas CA; Santos RD; Mercier F; Blom D;
    Eur J Prev Cardiol; 2018 Jul; 25(10):1087-1094. PubMed ID: 29771156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
    Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors.
    Breuker C; Clement F; Mura T; Macioce V; Castet-Nicolas A; Audurier Y; Boegner C; Morcrette E; Jalabert A; Villiet M; Avignon A; Sultan A
    Int J Cardiol; 2018 Oct; 268():195-199. PubMed ID: 30041785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gap between the current dyslipidemia guidelines and the physicians' treatment targets in patients with type 2 diabetes in Turkey.
    Kahya Eren N; Harman E; Dolek D; Emren S; Tütüncüoğlu AP; Nazli C; Ergene O
    Minerva Cardioangiol; 2014 Jun; 62(3):287-95. PubMed ID: 24831765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL-C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study.
    Ding R; Ye P; Zhao S; Zhao D; Yan X; Dong Y; Li J; Ran Y; Hu D;
    J Glob Health; 2017 Dec; 7(2):020702. PubMed ID: 29057073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study.
    Palazón-Bru A; Gil-Guillén VF; Orozco-Beltrán D; Pallarés-Carratalá V; Valls-Roca F; Sanchís-Domenech C; Martín-Moreno JM; Redón J; Navarro-Pérez J; Fernández-Giménez A; Pérez-Navarro AM; Trillo JL; Usó R; Ruiz E
    PLoS One; 2014; 9(3):e91567. PubMed ID: 24626597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the gap between National Cholesterol Education Program guidelines and clinical practice in secondary care: results of a cross-sectional study involving over 10 000 patients followed in different specialty settings across Italy.
    Rapezzi C; Biagini E; Bellis P; Cafiero M; Velussi M; Ceriello A; Cooke RM; Schweiger C;
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):878-87. PubMed ID: 18695423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic inertia in the outpatient management of dyslipidemia in patients with ischemic heart disease. The inertia study.
    Lázaro P; Murga N; Aguilar D; Hernández-Presa MA;
    Rev Esp Cardiol; 2010 Dec; 63(12):1428-37. PubMed ID: 21144403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care.
    Lee JA; Sunwoo S; Kim YS; Oh HJ; Kang HC; Park KC; Sin DH; Lee SY; Yang YJ; Yu BY; Kim CM
    Curr Med Res Opin; 2013 Jul; 29(7):751-60. PubMed ID: 23647398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat-to-Muscle Ratios and the Non-Achievement of LDL Cholesterol Targets: Analysis of the Korean Genome and Epidemiology Study.
    Cho AR; Lee JH; Kwon YJ
    J Cardiovasc Dev Dis; 2021 Aug; 8(8):. PubMed ID: 34436238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of low-density lipoprotein cholesterol levels in South Africa: the International ChoLesterol management Practice Study (ICLPS).
    Blom DJ; Raal F; Amod A; Naidoo P; Lai YE;
    Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):15-23. PubMed ID: 30720848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.